SOD3 and breast cancer: The in silico expression analysis revealed a decrease in SOD3 expression in BC, with a mean expression of 33.8 in BC patients and a mean expression of 182.1 in healthy controls (logFC −3.24, p = 5.6 × 10−23) (Figure 2).